Literature DB >> 32352022

Urticarial exanthem as early diagnostic clue for COVID-19 infection.

Lucía Quintana-Castanedo1, Marta Feito-Rodríguez1, Iván Valero-López2, Clara Chiloeches-Fernández1, Elena Sendagorta-Cudós1, Pedro Herranz-Pinto1.   

Abstract

Entities:  

Keywords:  COVID-19; COVID-19, coronavirus disease 2019; coronavirus disease; exanthem; rash

Year:  2020        PMID: 32352022      PMCID: PMC7189196          DOI: 10.1016/j.jdcr.2020.04.026

Source DB:  PubMed          Journal:  JAAD Case Rep        ISSN: 2352-5126


× No keyword cloud information.

Introduction

During the coronavirus disease 2019 (COVID-19) epidemic, dermatologists and other physicians have been treating patients with cutaneous manifestations related to this infection. Because of the high risk of taking photographs of these patients, there are few clinical images reported in the literature.

Case report

A 61-year-old Spanish physician came to the emergency department with a 4-day history of a progressive cutaneous rash. He had been treating patients with coronavirus infection for 3 weeks. On presentation, his temperature was 37.3°C. He did not complain of respiratory symptoms (such as cough or dyspnea), headache, malaise, sore throat, or nasal congestion. The patient also denied receiving any drugs during the last 2 months. Physical examination showed an urticarial rash consisting of confluent, edematous, and erythematous papules on his thighs, arms, and forearms (Fig 1, A and B). Palms and soles were spared. Cutaneous lesions were mildly itchy. COVID-19 infection was suspected because of the current epidemiologic situation. A nasopharyngeal sample was obtained and reverse-transcription polymerase chain reaction confirmed the diagnosis of COVID-19 infection. Other common viral infections such as parvovirus B19, rubella, measles, Epstein-Barr, human herpes virus 6, and enterovirus that might cause fever and rash were ruled out by laboratory investigation. A chest radiograph did not reveal lung abnormalities. Because the patient had no risk factors, in accordance with Spanish guidelines he did not receive any specific treatment for the infection. He remained afebrile during the next week. Cutaneous rash resolved in 7 days. The patient received only oral antihistamine because of mild pruritus.
Fig 1

A and B, Urticarial exanthem on the thighs.

A and B, Urticarial exanthem on the thighs.

Discussion

Like other types of RNA viruses, COVID-19 infection can present with cutaneous findings. There are only 2 reports of cutaneous manifestations with COVID-19 disease.1, 2, 3 However, neither of them reported clinical images because of the high risk of infection by introducing a photographic device in patients' rooms. COVID-19 infection can present with cutaneous findings. Some of these patients are afebrile and develop cutaneous manifestations at the onset, without any other symptoms. The key aspect in this COVID-19 epidemic is to prevent transmission. This may pose a challenge in asymptomatic patients and in those with atypical symptoms. Professionals should recognize the possibility that a patient might have only a rash as a symptom of COVID-19 and think of this disease to promptly prevent transmission.
  3 in total

1.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

2.  COVID-19 in medical personnel: observation from Thailand.

Authors:  B Joob; V Wiwanitkit
Journal:  J Hosp Infect       Date:  2020-02-27       Impact factor: 3.926

3.  COVID-19 can present with a rash and be mistaken for dengue.

Authors:  Beuy Joob; Viroj Wiwanitkit
Journal:  J Am Acad Dermatol       Date:  2020-03-22       Impact factor: 15.487

  3 in total
  27 in total

Review 1.  Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19).

Authors:  J M Carrascosa; V Morillas; I Bielsa; M Munera-Campos
Journal:  Actas Dermosifiliogr       Date:  2020-10-15

2.  Cutaneous Manifestations of Coronavirus Disease 2019: Skin Narratives and Dialogues.

Authors:  Ghada Farouk Mohammed; Mohammed Saleh Al-Dhubaibi; Lina Atef
Journal:  J Clin Aesthet Dermatol       Date:  2022-05

Review 3.  Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride.

Authors:  Ignacio J Ansotegui; Jonathan A Bernstein; Giorgio W Canonica; Sandra N Gonzalez-Diaz; Bryan L Martin; Mario Morais-Almeida; Margarita Murrieta-Aguttes; Mario Sanchez Borges
Journal:  Allergy Asthma Clin Immunol       Date:  2022-05-13       Impact factor: 3.373

4.  A systematic review of the histopathologic survey on skin biopsies in patients with Corona Virus Disease 2019 (COVID-19) who developed virus or drug-related mucocutaneous manifestations.

Authors:  Niloufar Najar Nobari; Farnoosh Seirafianpour; Milad Dodangeh; Afsaneh Sadeghzadeh-Bazargan; Elham Behrangi; Samaneh Mozafarpoor; Azadeh Goodarzi
Journal:  Exp Dermatol       Date:  2021-05-24       Impact factor: 4.511

Review 5.  Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19).

Authors:  J M Carrascosa; V Morillas; I Bielsa; M Munera-Campos
Journal:  Actas Dermosifiliogr (Engl Ed)       Date:  2020-08-31

Review 6.  Skin disorders associated with the COVID-19 pandemic: A review.

Authors:  Jennifer Akl; Jessica El-Kehdy; Antoine Salloum; Anthony Benedetto; Paula Karam
Journal:  J Cosmet Dermatol       Date:  2021-07-01       Impact factor: 2.189

Review 7.  Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue.

Authors:  A V Marzano; N Cassano; G Genovese; C Moltrasio; G A Vena
Journal:  Br J Dermatol       Date:  2020-07-05       Impact factor: 11.113

8.  Livedo reticularis as a presenting sign of severe acute respiratory syndrome coronavirus 2 infection.

Authors:  Shadi Khalil; Brian R Hinds; Iviensan F Manalo; Iris Monica Vargas; Sudhakar Mallela; Randy Jacobs
Journal:  JAAD Case Rep       Date:  2020-07-17

Review 9.  Patients with specific skin disorders who are affected by COVID-19: What do experiences say about management strategies? A systematic review.

Authors:  Niloufar Najar Nobari; Azadeh Goodarzi
Journal:  Dermatol Ther       Date:  2020-07-07       Impact factor: 3.858

Review 10.  Dermatologic manifestations and complications of COVID-19.

Authors:  Michael Gottlieb; Brit Long
Journal:  Am J Emerg Med       Date:  2020-06-06       Impact factor: 2.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.